Filing Details
- Accession Number:
- 0000950170-25-033997
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-03-05 18:55:37
- Reporting Period:
- 2025-03-03
- Filing Date:
- 2025-03-05
- Accepted Time:
- 2025-03-05 18:55:37
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1744659 | Akero Therapeutics Inc. | AKRO | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1961273 | Patrick Lamy | C/O Akero Therapeutics, Inc. 601 Gateway Blvd, Suite 350 South San Francisco CA 94080 | Senior Vp, Commercial Strategy | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-03-03 | 1,000 | $19.87 | 34,492 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-03-03 | 1,000 | $48.09 | 33,492 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-03-03 | 1,000 | $0.00 | 83,182 | $19.87 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 78,182 | 2033-12-07 | No | 4 | M | Direct |
Footnotes
- The reported transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 28, 2024, previously adopted by the Reporting Person.
- This option shall vest and become exercisable in 48 equal monthly installments, commencing on December 8, 2023.
Billionaire Hedge Funds
